• Support
  • Contact Us
  • Corporate website
  • Customer Care
  • Training

  • ScienceWatch Home
  • Inside This Month...
  • Interviews

Featured Interviews
Author Commentaries
Institutional Interviews
Journal Interviews
Podcasts

  • Analyses

Featured Analyses
What's Hot In...
Special Topics

  • Data & Rankings

Sci-Bytes
Fast Breaking Papers
New Hot Papers
Emerging Research Fronts
Fast Moving Fronts
Corporate Research Fronts
Research Front Maps
Current Classics
Top Topics
Rising Stars
New Entrants
Country Profiles

  • About Science Watch

Methodology
Archives
Contact Us
RSS Feeds

 ScienceWatch

2008 : October 2008 - Fast Breaking Papers : Jean-Antoine Girault

FAST BREAKING PAPERS - 2008

October 2008 Download this article
 
Jean-Antoine Girault talks with ScienceWatch.com and answers a few questions about this month's Fast Breaking Paper in the field of Pharmacology & Toxicology.
Girault Article Title: ERK2: a logical AND gate critical for drug-induced plasticity?
Authors: Girault, JA;Valjent, E;Caboche, J;Herve, D
Journal: CURR OPIN PHARMACOL
Volume: 7
Issue: 1
Page: 77-85
Year: FEB 2007
* INSERM, UMR S536, F-75005 Paris, France.
* INSERM, UMR S536, F-75005 Paris, France.
* Univ Paris 06, F-75005 Paris, France.
(addresses have been truncated)

Why do you think your paper is highly cited?

It is a review which synthesizes current knowledge and proposes a new hypothesis. It may provide a useful framework for understanding the physiological significance of signaling pathways in striatal neurons, in relation to the actions of drugs of abuse.

Would you summarize the significance of your paper in layman's terms?

"In this article we review the mode of action of dopamine on target cells at a molecular level..."

Animals adapt their behavior to a changing environment thanks to powerful learning mechanisms, including reinforcement, in response to rewards. Dopamine, a chemical released in specific brain areas by a particular group of neurons, plays an important role in these learning mechanisms. In this article we review the mode of action of dopamine on target cells at a molecular level, focusing on an important enzyme named "extracellular signal-regulated kinase" or ERK.

Recent evidence shows that activation of ERK is important for long-term cellular alterations which underlie behavioral changes. We argue that ERK plays an important role by detecting the simultaneous activation of neurons that use glutamate as neurotransmitter and code information related to the environment in which the animal exists, and of dopamine neurons which signal a reward. We propose that this mechanism is hijacked by drugs of abuse which artificially increase dopamine levels.

How did you become involved in this research, and were there any problems along the way?

We have been interested in the action of dopamine for many years since it is a central neuromodulator in the brain, which is involved in a variety of pathological conditions in humans.

Where do you see your research leading in the future?

We shall continue the dissection of the basic mechanism involved in incentive learning and in its diversion by drugs of abuse as well as in other pathological circumstances, including Parkinson's disease.

Do you foresee any social or political implications for your research?

Since drug abuse is a widespread health problem with important societal consequences, progress in understanding the brain mechanisms underlying this pathology will help to fight against it with a better efficacy and possibly discover new therapeutic strategies.

Jean-Antoine Girault, M.D., Ph.D.
Director
Institut du Fer à Moulin
INSERM and Pierre & Marie Curie University
Paris, France

Keywords: signaling pathways in striatal neurons, drugs of abuse, dopamine, a central neuromodulator in the brain, extracellular signal-regulated kinase, long-term cellular alterations which underlie behavioral changes, neurons that use glutamate as neurotransmitter, dopamine neurons which signal a reward.

Download this article

back to top


2008 : October 2008 - Fast Breaking Papers : Jean-Antoine Girault

  • © 2020 Clarivate
  • Careers
  • Copyright
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
Follow us Share to Twitter Share to LinkedIn Share to Facebook Share to Instagram
Previous
left arrow key
Next
right arrow key
Close Move